These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2393441)

  • 1. Rapid opioid detoxification with electrosleep and naloxone.
    Westermeyer J
    Am J Psychiatry; 1990 Jul; 147(7):952-3. PubMed ID: 2393441
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid detoxification from opioid dependence.
    Kosten TR; Krystal JH; Charney DS; Price LH; Morgan CH; Kleber HD
    Am J Psychiatry; 1989 Oct; 146(10):1349. PubMed ID: 2675644
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical treatment of opioid dependence within the South African context.
    Weich L
    SADJ; 2010 May; 65(4):168-71. PubMed ID: 20632700
    [No Abstract]   [Full Text] [Related]  

  • 4. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
    Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T
    Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Less pain, more gain: buprenorphine-naloxone and patient retention in treatment.
    Renzelli CM; Capretto NA
    J Addict Dis; 2006; 25(3):97-104. PubMed ID: 16956874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid opiate detoxification with clonidine and naloxone.
    Riordan CE; Kleber HD
    Lancet; 1980 May; 1(8177):1079-80. PubMed ID: 6103408
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid opioid detoxification during general anesthesia: a review of 20 patients.
    Gold CG; Cullen DJ; Gonzales S; Houtmeyers D; Dwyer MJ
    Anesthesiology; 1999 Dec; 91(6):1639-47. PubMed ID: 10598605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol for sedation during rapid opiate detoxification.
    Demaria PA; Rodgers C; Braccia G
    Am J Psychiatry; 1997 Feb; 154(2):290-1. PubMed ID: 9016290
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating opiate addiction, Part I. Detoxification and maintenance.
    Harv Ment Health Lett; 2004 Dec; 21(6):4-6. PubMed ID: 15717347
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
    Kosten TR; Morgan C; Kleber HD
    NIDA Res Monogr; 1992; 121():101-19. PubMed ID: 1406906
    [No Abstract]   [Full Text] [Related]  

  • 11. Opiate detoxification under anaesthesia.
    Strang J; Bearn J; Gossop M
    BMJ; 1997 Nov; 315(7118):1249-50. PubMed ID: 9390045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurochemical basis of ultra rapid opioid detoxication].
    Golovko AI; Leont'eva LV; Golovko SI; Zefirov SIu; Konoplin DA; Romanenko OP
    Vopr Med Khim; 2002; 48(2):154-73. PubMed ID: 12189623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone-induced withdrawal in patients with buprenorphine dependence.
    Nigam AK; Srivastava RP; Saxena S; Chavan BS; Sundaram KR
    Addiction; 1994 Mar; 89(3):317-20. PubMed ID: 8173501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and ultrarapid opioid detoxification techniques.
    O'Connor PG; Kosten TR
    JAMA; 1998 Jan; 279(3):229-34. PubMed ID: 9438745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
    McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD
    J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.
    Meade CS; Lukas SE; McDonald LJ; Fitzmaurice GM; Eldridge JA; Merrill N; Weiss RD
    J Subst Abuse Treat; 2010 Jan; 38(1):12-21. PubMed ID: 19574017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction: a nurse's story. Opioids became an obsession--until he was caught.
    Hastings J; Burn J
    Am J Nurs; 2007 Aug; 107(8):75-7, 79. PubMed ID: 17695670
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E; Godfroid IO; Guillaume R
    Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.